TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: ASCO Selects Four New Board Members; Mount Sinai’s Shank To Move To California March 27, 1998
TCL Archive PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract February 17, 1995